{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:43Z","timestamp":1793832343492,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301924"],"award-info":[{"award-number":["82301924"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00228-025-03804-y","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T14:53:25Z","timestamp":1737471205000},"page":"465-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety profiles of fondaparinux in pregnant women: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"81","author":[{"given":"Dan","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurou","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"3804_CR1","doi-asserted-by":"publisher","unstructured":"Middleton P, Shepherd E, Gomersall JC (2021) Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Syst Rev 3 (3): CD001689.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD001689.pub4","DOI":"10.1002\/14651858.CD001689.pub4"},{"issue":"2","key":"3804_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/187152571302151217124957","volume":"13","author":"RK Chaudhary","year":"2015","unstructured":"Chaudhary RK, Nepal C, Khanal N, Pathak R, Giri S, Bhatt VR (2015) Management and Outcome of Heparin-Induced Thrombocytopenia in Pregnancy: A Systematic Review. Cardiovasc Hematol Agents Med Chem 13(2):92\u201397. https:\/\/doi.org\/10.2174\/187152571302151217124957","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"4","key":"3804_CR3","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.3928\/01477447-20130327-17","volume":"36","author":"K Hosaka","year":"2013","unstructured":"Hosaka K, Saito S, Ishii T, Sumino T, Ryu K, Suzuki G, Suzuki T, Tokuhashi Y (2013) Safety of fondaparinux versus enoxaparin after TKA in Japanese patients. Orthopedics 36(4):e428-433. https:\/\/doi.org\/10.3928\/01477447-20130327-17","journal-title":"Orthopedics"},{"issue":"1","key":"3804_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40800-015-0018-0","volume":"2","author":"KJ Hahn","year":"2015","unstructured":"Hahn KJ, Morales SJ, Lewis JH (2015) Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS). Drug Saf Case Rep 2(1):17. https:\/\/doi.org\/10.1007\/s40800-015-0018-0","journal-title":"Drug Saf Case Rep"},{"issue":"2","key":"3804_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000508471","volume":"14","author":"S Mehershahi","year":"2020","unstructured":"Mehershahi S, Mantri N, Kumar A, Danial S, Harish P (2020) Enoxaparin-Induced Liver Injury. Case Rep Gastroenterol 14(2):315\u2013319. https:\/\/doi.org\/10.1159\/000508471","journal-title":"Case Rep Gastroenterol"},{"issue":"7","key":"3804_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.gastrohep.2014.06.010","volume":"38","author":"C Zaera De La Fuente","year":"2015","unstructured":"Zaera De La Fuente C, Arribas Anta J, L\u00f3pez-San Rom\u00e1n A, Ca\u00f1ete Ruiz \u00c1, L\u00f3pez Dur\u00e1n S (2015) Enoxaparin-induced hepatotoxicity. Gastroenterol Hepatol 38(7):438\u2013439. https:\/\/doi.org\/10.1016\/j.gastrohep.2014.06.010","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"3804_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.thromres.2015.04.001","volume":"135","author":"S De Carolis","year":"2015","unstructured":"De Carolis S, di Pasquo E, Rossi E, Del Sordo G, Buonomo A, Schiavino D, Lanzone A, De Stefano V (2015) Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. Thromb Res 135(6):1049\u20131051. https:\/\/doi.org\/10.1016\/j.thromres.2015.04.001","journal-title":"Thromb Res"},{"issue":"4","key":"3804_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.thromres.2011.10.037","volume":"129","author":"M Nagler","year":"2012","unstructured":"Nagler M, Haslauer M, Wuillemin WA (2012) Fondaparinux - data on efficacy and safety in special situations. Thromb Res 129(4):407\u2013417. https:\/\/doi.org\/10.1016\/j.thromres.2011.10.037","journal-title":"Thromb Res"},{"issue":"2","key":"3804_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/1753495x12472642","volume":"6","author":"AW Tang","year":"2013","unstructured":"Tang AW, Greer I (2013) A systematic review on the use of new anticoagulants in pregnancy. Obstet Med 6(2):64\u201371. https:\/\/doi.org\/10.1177\/1753495x12472642","journal-title":"Obstet Med"},{"key":"3804_CR10","doi-asserted-by":"publisher","unstructured":"American College of O, Gynecologists' Committee on Practice B-O (2018) ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstet Gynecol 132 (1): e1-e17.\u00a0https:\/\/doi.org\/10.1097\/AOG.0000000000002706","DOI":"10.1097\/AOG.0000000000002706"},{"key":"3804_CR11","unstructured":"Royal College of Obstetricians and Gynaecologists (2015) Green-top Guideline No. 37a. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg37a\/. Accessed October 10 2023."},{"key":"3804_CR12","unstructured":"Food and Drug Administration (2001) Accessed October 11, 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2001\/21-345_Arixtra_Approv.pdf."},{"key":"3804_CR13","unstructured":"European Medicines Agency (2010) Accessed October 11, 2023. https:\/\/www.ema.europa.eu\/en\/documents\/overview\/arixtra-epar-summary-public_en.pdf."},{"key":"3804_CR14","doi-asserted-by":"publisher","first-page":"107424842211450","DOI":"10.1177\/10742484221145010","volume":"28","author":"RM Bauersachs","year":"2023","unstructured":"Bauersachs RM (2023) Fondaparinux Sodium: Recent Advances in the Management of Thrombosis. J Cardiovasc Pharmacol Ther 28:10742484221145010. https:\/\/doi.org\/10.1177\/10742484221145010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"3804_CR15","doi-asserted-by":"publisher","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (15): 2008\u20132012.\u00a0https:\/\/doi.org\/10.1001\/jama.283.15.2008","DOI":"10.1001\/jama.283.15.2008"},{"issue":"5","key":"3804_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (London, England) 8(5):336\u2013341. https:\/\/doi.org\/10.1016\/j.ijsu.2010.02.007","journal-title":"Int J Surg (London, England)"},{"key":"3804_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.envint.2018.08.018","volume":"120","author":"RL Morgan","year":"2018","unstructured":"Morgan RL, Thayer KA, Santesso N, Holloway AC, Blain R, Eftim SE, Goldstone AE, Ross P, Guyatt G, Schunemann HJ (2018) Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the \u201ctarget experiment\u201d concept in studies of exposures: Rationale and preliminary instrument development. Environ Int 120:382\u2013387. https:\/\/doi.org\/10.1016\/j.envint.2018.08.018","journal-title":"Environ Int"},{"issue":"3","key":"3804_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/xeb.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 13(3):147\u2013153. https:\/\/doi.org\/10.1097\/xeb.0000000000000054","journal-title":"Int J Evid Based Healthc"},{"key":"3804_CR19","doi-asserted-by":"crossref","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ (2019) Assessing risk of bias in a andomized trial. In: Higgins JPT, Thomas J, Chandler J, et al., eds. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collaboration: 205\u2013228","DOI":"10.1002\/9781119536604.ch8"},{"issue":"3","key":"3804_CR20","first-page":"1","volume":"36","author":"V Wolfgang","year":"2010","unstructured":"Wolfgang V (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1\u201348","journal-title":"J Stat Softw"},{"key":"3804_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160","journal-title":"Evid Based Ment Health"},{"key":"3804_CR22","doi-asserted-by":"publisher","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67 (11): 974\u2013978.\u00a0https:\/\/doi.org\/10.1136\/jech-2013-203104","DOI":"10.1136\/jech-2013-203104"},{"issue":"7414","key":"3804_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clinical research ed) 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ (Clinical research ed)"},{"issue":"7650","key":"3804_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed) 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ (Clinical research ed)"},{"key":"3804_CR25","doi-asserted-by":"publisher","first-page":"107602962110145","DOI":"10.1177\/10760296211014575","volume":"27","author":"CE Dempfle","year":"2021","unstructured":"Dempfle CE, Koscielny J, Lindhoff-Last E, Linnemann B, Bux-Gewehr I, Kappert G, Scholz U, Kropff S, Eberle S, Bramlage P, Heinken A (2021) Fondaparinux Pre-, Peri-, and\/or Postpartum for the Prophylaxis\/Treatment of Venous Thromboembolism (FondaPPP). Clin Appl Thromb Hemost 27:10760296211014576. https:\/\/doi.org\/10.1177\/10760296211014575","journal-title":"Clin Appl Thromb Hemost"},{"key":"3804_CR26","first-page":"5","volume":"26","author":"Z Guo","year":"2020","unstructured":"Guo Z, Liu C, Guo X, Zhang Y, X. L, (2020) Comparison between enoxaparin and fondaparinux sodium on anticoagulant therapy in pregnant patient with recurrent miscarriage. Contemporary Med (Chin) 26:5\u20138","journal-title":"Contemporary Med (Chin)"},{"issue":"2","key":"3804_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1620\/tjem.2023.J098","volume":"262","author":"C Liu","year":"2024","unstructured":"Liu C, Ma C, Hao Y (2024) Fondaparinux Results in Similar Pregnancy Outcomes with Lower Adverse Reaction Rates Compared to Low Molecular Weight Heparin in Chinese Recurrent Miscarriage Women. Tohoku J Exp Med 262(2):125\u2013131. https:\/\/doi.org\/10.1620\/tjem.2023.J098","journal-title":"Tohoku J Exp Med"},{"key":"3804_CR28","unstructured":"Liu H, Wang A, X. S (2021) Effect of enoxaparin and fondaparinux in anticoagulant therapy for re-pregnant women with recurrent miscarriage. Chin J Pract Med (Chin) 48:106\u20139"},{"key":"3804_CR29","doi-asserted-by":"publisher","first-page":"887020","DOI":"10.3389\/fphar.2022.887020","volume":"13","author":"N Muhamad","year":"2022","unstructured":"Muhamad N, Abu MA, Kalok AH, Shafiee MN, Shah SA, Ismail NAM (2022) Safety and effectiveness of fondaparinux as a postpartum thromboprophylaxis during puerperium among muslim women: A single centre prospective study. Front Pharmacol 13:887020. https:\/\/doi.org\/10.3389\/fphar.2022.887020","journal-title":"Front Pharmacol"},{"issue":"4","key":"3804_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1600-0897.2009.00733.x","volume":"62","author":"EE Winger","year":"2009","unstructured":"Winger EE, Reed JL (2009) A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss. Am J Reprod Immunol 62(4):253\u2013260. https:\/\/doi.org\/10.1111\/j.1600-0897.2009.00733.x","journal-title":"Am J Reprod Immunol"},{"issue":"10","key":"3804_CR31","first-page":"55","volume":"60","author":"Ni Yang","year":"2022","unstructured":"Yang N, Lin J, Chen ZY, Li WW, Huang JF, Liu JH, Shen SJ (2022) Comparison of curative effect of fondaparinux sodium and low molecularweight heparin on recurrent spontaneous abortion. China Mordern Doctor (Chin) 60(10):55\u201358","journal-title":"China Mordern Doctor (Chin)"},{"key":"3804_CR32","doi-asserted-by":"publisher","first-page":"717630","DOI":"10.3389\/fendo.2021.717630","volume":"12","author":"L Zhao","year":"2021","unstructured":"Zhao L, Bi S, Fu J, Qi L, Li L, Fu Y (2021) Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion. Front Endocrinol (Lausanne) 12:717630. https:\/\/doi.org\/10.3389\/fendo.2021.717630","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"23","key":"3804_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.19335\/j.cnki.2096-1219.2022.23.033","volume":"8","author":"Lu Li","year":"2022","unstructured":"Li L, Tan Y (2022) To Compare the Pregnancy Outcome and Incidence of Adverse Events in Patients with Recurrent Abortion Treated with Enoxaparin and Sulfondaigan Sodium. Smart Healthcare (Chin) 8(23):139\u2013142. https:\/\/doi.org\/10.19335\/j.cnki.2096-1219.2022.23.033","journal-title":"Smart Healthcare (China)"},{"key":"3804_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejogrb.2023.05.031","volume":"287","author":"F Mu","year":"2023","unstructured":"Mu F, Wang M, Huang J, Wang F (2023) Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis. Eur J Obstet Gynecol Reprod Biol 287:29\u201335. https:\/\/doi.org\/10.1016\/j.ejogrb.2023.05.031","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"3804_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12872-017-0552-z","volume":"17","author":"PK Bundhun","year":"2017","unstructured":"Bundhun PK, Shaik M, Yuan J (2017) Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis. BMC Cardiovasc Disord 17(1):116. https:\/\/doi.org\/10.1186\/s12872-017-0552-z","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"3804_CR36","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/ajh.26194","volume":"96","author":"H Nilius","year":"2021","unstructured":"Nilius H, Kaufmann J, Cuker A, Nagler M (2021) Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia. Am J Hematol 96(7):805\u2013815. https:\/\/doi.org\/10.1002\/ajh.26194","journal-title":"Am J Hematol"},{"issue":"5","key":"3804_CR37","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/bjh.13147","volume":"168","author":"E Elsaigh","year":"2015","unstructured":"Elsaigh E, Thachil J, Nash MJ, Tower C, Hay CR, Bullough S, Byrd L (2015) The use of fondaparinux in pregnancy. Br J Haematol 168(5):762\u2013764. https:\/\/doi.org\/10.1111\/bjh.13147","journal-title":"Br J Haematol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03804-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:11:16Z","timestamp":1742368276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03804-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03804-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this review, as all data were already published in peer-reviewed journals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}